Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Non-Current Deferred Tax Liability came in at $17.1 million in Q1 2026, up 27.5% year-on-year from $13.4 million in Q1 2025, and up 11.0% on a QoQ basis from $15.4 million in Q4 2025.

Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $17.1 million in Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 27.5% year-over-year to $17.1 million in Q1 2026; TTM through Mar 2026 was $17.1 million, a 27.5% increase from a year earlier, with the FY2025 full-year figure at $15.4 million, up 214.63% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $17.1 million, up from $15.4 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for STVN reached as high as $23.1 million in Q2 2023 and fell as low as -$21.4 million in Q4 2022.
  • Historically, Non-Current Deferred Tax Liability has averaged $11.0 million across 5 years, with a median of $14.6 million in 2025.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 233.43% in 2022 and plunged 53.27% in 2023, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at -$21.4 million in 2022, then jumped by 51.79% to -$10.3 million in 2023, then slumped by 30.35% to -$13.5 million in 2024, then surged by 214.63% to $15.4 million in 2025, then increased by 11.0% to $17.1 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $17.1 million in Q1 2026, $15.4 million in Q4 2025, and $15.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Stevanato Group S.p.A 5.29 Bn 5.15 Bn 88.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17.13 Mn
Mar 31, 2026 17.13 Mn
Dec 31, 2025 15.43 Mn
Dec 31, 2025 15.43 Mn
Sep 30, 2025 15.49 Mn
Sep 30, 2025 15.49 Mn
Jun 30, 2025 14.63 Mn
Jun 30, 2025 14.63 Mn
Mar 31, 2025 13.44 Mn
Mar 31, 2025 13.44 Mn
Dec 31, 2024 -13.46 Mn
Dec 31, 2024 -13.46 Mn
Sep 30, 2024 11.88 Mn
Sep 30, 2024 11.88 Mn
Jun 30, 2024 11.38 Mn
Jun 30, 2024 11.38 Mn
Mar 31, 2024 11.10 Mn
Mar 31, 2024 11.10 Mn
Dec 31, 2023 -10.33 Mn
Dec 31, 2023 -10.33 Mn